coronavirus
recogn
anim
pathogen
thirti
year
later
coronavirus
identifi
human
respiratori
pathogen
first
recogn
hcov
strain
includ
strain
also
describ
character
coronaviruslik
particl
detect
stool
primarili
infant
gastroenter
necrot
enterocol
character
complet
sever
acut
respiratori
syndrom
sar
cov
identifi
novel
respiratori
pathogen
respons
global
outbreak
sar
first
emerg
china
outbreak
last
month
result
peopl
infect
death
data
suggest
sar
cov
evolv
sar
covlik
virus
horsesho
bat
civet
cat
wild
market
anim
serv
intermedi
host
renew
interest
cov
research
let
discoveri
two
novel
hcov
year
later
also
known
nl
nh
human
cov
identifi
human
cov
identifi
detect
human
respiratori
sampl
earli
unclear
relat
hcov
strain
origin
describ
ie
enter
coronaviruslik
particl
detect
stool
middl
east
respiratori
syndrom
mer
cov
also
call
hcovemc
identifi
novel
cov
respons
epidem
respiratori
ill
kingdom
saudi
arabia
data
suggest
mer
cov
like
evolv
bat
cov
camel
act
intermedi
host
total
case
death
associ
mer
cov
may
found
worldwid
caus
diseas
predominantli
winter
spring
month
temper
climat
seropreval
data
suggest
exposur
common
earli
childhood
sar
cov
identifi
sinc
sporad
communityacquir
case
sar
identifi
china
case
link
laboratori
biosafeti
practic
breach
identifi
southeast
asia
outbreak
sar
cov
transmiss
occur
within
hospit
patient
unrecogn
ill
mer
cov
case
continu
middl
east
primarili
link
exposur
camel
camel
product
close
contact
unrecogn
case
hospit
patient
household
transmiss
also
occur
larg
outbreak
mer
cov
south
korea
affect
case
associ
death
trace
individu
return
travel
middl
east
mode
transmiss
hcov
sar
cov
mer
cov
well
studi
base
studi
respiratori
virus
transmiss
like
occur
primarili
combin
spread
droplet
direct
indirect
contact
possibl
role
aerosol
spread
need
studi
droplet
spread
direct
contact
like
common
mode
transmiss
sar
cov
although
evid
spread
indirect
contact
aerosol
also
part
iii
etiolog
agent
infecti
diseas
exist
evid
vertic
transmiss
sar
cov
transmiss
mer
cov
thought
occur
droplet
contact
possibl
aerosol
rout
like
transmit
first
day
ill
symptom
respiratori
tract
viral
load
maxim
studi
need
confirm
also
case
sar
cov
mer
cov
like
transmit
second
week
ill
symptom
viral
load
respiratori
tract
peak
supershed
event
associ
sar
cov
mer
cov
incub
period
day
median
day
studi
need
confirm
incub
period
incub
period
sar
cov
day
median
day
incub
mer
cov
day
median
day
pathogenesi
hcov
best
describ
sar
cov
mer
cov
sar
cov
evid
infect
adult
children
affect
outbreak
human
coronaviru
infect
initi
inocul
respiratori
tract
mucos
surfac
nasal
mucos
plasma
exud
increas
interferon
level
nasal
lavag
specimen
correl
symptom
sever
respiratori
tract
viral
load
peak
within
first
day
infect
drop
dramat
week
correl
develop
improv
symptom
antibodi
detect
week
correl
drop
viral
load
reach
maxim
level
approxim
week
later
declin
thereaft
immun
complet
reinfect
common
higher
circul
antibodi
level
especi
level
specif
iga
antihcov
correl
reduc
symptom
reduc
viru
shed
reexposur
sever
acut
respiratori
syndrom
coronaviru
sar
cov
infect
initi
inocul
respiratori
tract
mucosa
use
angiotensinconvert
enzym
act
function
receptor
cell
entri
viremia
replic
lung
gastrointestin
tract
follow
replic
site
like
occur
given
wide
distribut
sar
cov
tissu
examin
autopsi
peak
viral
load
nasopharyng
specimen
detect
second
week
symptom
rise
sar
covspecif
antibodi
typic
seen
time
increas
antibodi
titer
symptomat
improv
second
third
week
associ
decreas
sar
cov
viral
load
paradox
despit
fall
viral
load
rise
sarsspecif
antibodi
clinic
deterior
observ
patient
host
immun
respons
like
contribut
clinic
deterior
patient
elev
level
inflammatori
cytokin
neutrophil
chemokin
monocyt
chemoattract
protein
detect
level
correl
sever
diseas
middl
east
respiratori
syndrom
coronaviru
mer
cov
infect
like
initi
inocul
respiratori
tract
mucosa
mediat
dipeptidyl
peptidas
ie
act
function
receptor
viral
load
highest
lower
respiratori
tract
specimen
realtim
polymeras
chain
reaction
rtpcr
evid
mer
cov
also
found
upper
respiratori
tract
serum
stool
urin
autopsi
data
singl
patient
show
extrapulmonari
mer
cov
dissemin
wide
distribut
differ
tissu
extrapulmonari
dissemin
thought
possibl
human
coronavirus
hcov
commonli
associ
common
cold
typic
character
rhinorrhea
nasal
congest
sore
throat
sneez
cough
may
associ
fever
togeth
hcov
second
common
caus
common
cold
rhinovirus
base
data
symptom
typic
peak
day
ill
selflimit
hcov
also
may
associ
acut
otiti
media
exacerb
asthma
less
frequent
virus
associ
lower
respiratori
tract
infect
includ
bronchiol
pneumonia
primarili
infant
immunocompromis
children
adult
compar
hcov
frequent
associ
croup
second
common
caus
parainfluenza
viru
type
possibl
associ
kawasaki
diseas
substanti
associ
symptom
gastroenter
includ
vomit
diarrhea
typic
occur
along
respiratori
symptom
also
appear
frequent
associ
febril
seizur
compar
hcov
sever
acut
respiratori
syndrom
coronaviru
sar
cov
associ
sever
symptom
sar
cov
disproportion
affect
adult
typic
manifest
fever
myalgia
headach
malais
chill
follow
nonproduct
cough
dyspnea
day
later
approxim
develop
wateri
diarrhea
respiratori
distress
progress
requir
intub
ventil
case
overal
associ
mortal
rate
approxim
death
occur
third
week
ill
casefat
rate
person
older
year
age
approach
typic
laboratori
abnorm
includ
lymphopenia
increas
serum
lactat
dehydrogenas
ldh
creatin
kinas
level
patient
progress
unilater
bilater
illdefin
airspac
infiltr
chest
imag
pneumothorac
sign
barotrauma
common
patient
receiv
mechan
ventil
infant
children
younger
year
age
develop
sar
typic
fever
cough
rhinorrhea
milder
symptom
compar
adolesc
adult
associ
lymphopenia
less
sever
radiograph
chang
milder
usual
resolv
quickli
adolesc
adult
infant
children
die
sar
cov
infect
outbreak
adolesc
develop
sar
clinic
cours
close
resembl
adult
includ
fever
myalgia
headach
chill
like
dyspnea
hypoxemia
worsen
chest
radiograph
find
women
infect
sar
cov
pregnanc
surviv
increas
risk
spontan
miscarriag
preterm
deliveri
intrauterin
growth
restrict
two
neonat
born
mother
sar
outbreak
develop
gastrointestin
complic
eg
jejun
perfor
necrot
enterocol
ileal
perfor
soon
birth
neither
clinic
evid
sar
cov
infect
unclear
whether
find
relat
complic
matern
sar
treatment
sar
ribavirin
corticosteroid
use
pregnanc
middl
east
respiratori
syndrom
coronaviru
mer
cov
infect
associ
sever
symptom
similar
seen
sar
cov
although
spectrum
diseas
includ
asymptomat
infect
mild
diseas
occur
case
identifi
male
adult
comorbid
infect
children
typic
milder
symptom
fever
myalgia
chill
follow
day
later
nonproduct
cough
dyspnea
approxim
patient
also
vomit
diarrhea
abdomin
pain
rapid
deterior
oxygen
progress
unilater
bilater
airspac
infiltr
chest
imag
may
follow
requir
mechan
ventil
often
associ
acut
renal
failur
laboratori
abnorm
includ
thrombocytopenia
lymphopenia
elev
ldh
level
casefat
rate
high
estim
laboratori
offer
comprehens
rtpcr
respiratori
tract
specimen
may
includ
detect
hcov
public
health
laboratori
offer
rtpcr
antibodi
test
sar
cov
mer
cov
test
upper
lower
respiratori
tract
specimen
appropri
sampl
viral
detect
test
avail
sinc
sar
outbreak
viral
entryand
proteaseinhibit
agent
rnainterf
agent
glycyrrhizin
test
vitro
appear
promis
howev
definit
conclus
drawn
sar
cov
reemerg
clarif
effect
treatment
control
clinic
trial
need
mer
cov
preliminari
data
suggest
sever
treatment
may
use
definit
recommend
made
time
practic
good
hand
respiratori
hygien
use
control
measur
curb
spread
respiratori
virus
includ
hcov
prophylact
intranas
reduc
durat
sever
infect
research
set
use
clinic
proprietari
extract
root
north
american
ginseng
panax
quinquefolium
reduc
number
cold
sever
durat
cold
symptom
adult
taken
daili
presum
due
immun
stimul
efficaci
decreas
number
cold
specif
due
hcov
studi
healthcar
personnel
use
gown
glove
mask
eye
protect
durat
ill
care
children
hospit
sign
symptom
respiratori
tract
infect
precaut
replac
mask
respir
avail
negativepressur
isol
recommend
patient
sar
cov
infect
durat
ill
day
resolut
fever
provid
respiratori
symptom
absent
improv
precaut
recommend
sar
cov
recommend
mer
cov
except
durat
precaut
decid
conjunct
public
health
author
standard
disinfect
use
clean
disinfect
environment
surfac
frequent
touch
infect
person
decreas
potenti
indirect
transmiss
hcov
fomit
control
sar
outbreak
credit
rapid
identif
case
earli
implement
infect
control
public
health
measur
includ
contact
trace
quarantin
sar
cov
reemerg
measur
sampl
frequent
posit
patient
sar
posit
mer
cov
infect
serum
sampl
also
may
posit
rtpcr
patient
sar
cov
mer
cov
infect
case
infect
specimen
like
posit
first
day
ill
whether
also
true
need
studi
sar
cov
infect
serum
sampl
rtpcr
test
like
posit
first
week
ill
respiratori
stool
specimen
may
posit
second
week
ill
symptom
viral
load
peak
infant
children
sar
cov
infect
less
like
posit
specimen
consist
milder
symptom
presum
correspondingli
lower
viral
load
children
case
mer
cov
infect
specimen
rtpcr
collect
lower
respiratori
upper
respiratori
tract
along
serum
stool
sampl
laboratori
guidanc
sar
cov
mer
cov
diagnost
test
avail
center
diseas
control
prevent
cdc
websit
potenti
falseposit
result
associ
public
health
implic
test
sar
cov
absenc
known
persontoperson
transmiss
done
consult
public
health
depart
high
degre
clinic
suspicion
similarli
test
mer
cov
done
consult
public
health
offici
context
known
risk
factor
mer
cov
infect
selflimit
natur
infect
hcov
strain
treatment
studi
perform
care
typic
support
sar
cov
infect
seriou
corticosteroid
type
ifn
agent
convalesc
plasma
ribavirin
lopinavir
ritonavir
use
treat
sar
mani
agent
anecdot
report
suggest
benefit
vitro
assay
anim
model
offer
support
data
except
ribavirin
vitro
studi
support
efficaci
hcov
strain
associ
common
cold
acut
otiti
media
asthma
exacerb
less
frequent
bronchiol
pneumonia
also
associ
croup
associ
vomit
diarrhea
frequent
respiratori
tract
symptom
appear
associ
frequent
febril
seizur
compar
hcov
sar
cov
caus
sar
attend
mortal
rate
primarili
affect
adult
adolesc
children
younger
year
age
develop
sar
typic
less
sever
manifest
ie
fever
cough
rhinorrhea
mer
cov
associ
spectrum
diseas
rang
asymptomat
mild
diseas
sever
respiratori
diseas
associ
mortal
rate
mer
cov
primarili
affect
male
adult
comorbid
children
mer
typic
milder
symptom
implement
urgent
attempt
prevent
recurr
worldwid
outbreak
transmiss
mer
cov
within
hospit
household
avert
use
infect
control
precaut
prevent
transmiss
camel
human
challeng
given
preval
use
camel
transport
meat
milk
recommend
reduc
likelihood
transmiss
includ
regul
camel
movement
enforc
use
person
protect
precaut
handl
camel
educ
public
risk
consum
unpasteur
camel
milk
urin
given
challeng
follow
recommend
like
sporad
transmiss
continu
effect
mer
cov
vaccin
found
refer
avail
onlin
wwwexpertconsultcom
